Schedule 13D ownership disclosure

IN8bio, Inc.

Common Stock, $0.0001 par value per share · CUSIP: 45674E208

Event date: 2025-12-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EMILY FAIRBAIRNReported CIK 0001682638

    Shares: 733,293.00 · Class: 7.5%

  • Malcom Fairbairn

    Shares: 727,681.00 · Class: 7.5%

  • Malcom and Emily Fairbairn 2010 CRUT

    Shares: 724,637.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001682638-26-000002
Form type
SCHEDULE 13D
Filer
FAIRBAIRN EMILY
CIK
CIK 1682638
Filed
Jan 02, 2026
Reporting period
Dec 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub